Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Gastroenterol Hepatol ; 29(1): 74-82, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23981141

RESUMO

BACKGROUND AND AIM: Although differences in genetic susceptibility and the clinical features of Crohn's disease (CD) have been reported between Asian and Caucasian patients, the disease course and predictors of CD in Asians remains poorly defined. The study therefore aimed to investigate factors predictive of the clinical outcomes of patients with CD in a Korean population. METHODS: This retrospective multicenter cohort study included 728 Korean CD patients from 13 university hospitals. The first CD-related surgery or need for immunosuppressive or biological agents were regarded as the clinical outcomes of interest. RESULTS: A total of 126 (17.3%) CD patients underwent CD-related surgery, while 473 (65.0%) and 196 (26.9%) were prescribed thiopurine drugs and infliximab, respectively. Multivariate Cox regression analysis identified current (hazard ratio [HR] = 1.86; P = 0.018) and former smoking habits (HR = 1.78; P = 0.049), stricturing (HR = 2.24; P < 0.001), and penetrating disease behavior at diagnosis (HR = 3.07; P < 0.001) as independent predictors associated with the first CD-related surgery. With respect to immunosuppressive and biological agents, younger age (< 40 years) (HR = 2.17; P < 0.001 and HR = 2.10; P = 0.006, respectively), ileal involvement (HR = 1.36; P = 0.035 and HR = 2.17; P = 0.006, respectively), and perianal disease (HR = 1.42; P = 0.001 and HR = 1.38; P = 0.038, respectively) at diagnosis were significant predictors for the need of these medications. CONCLUSIONS: In Korean patients with CD, stricturing, penetrating disease behavior, and smoking habits at the time of diagnosis are independent predictors for CD-related surgery. It was also identified that younger age (< 40 years), ileal involvement, and perianal disease at diagnosis are predictive of a need for immunosuppressive or biological agents.


Assuntos
Doença de Crohn/tratamento farmacológico , Doença de Crohn/cirurgia , Imunossupressores/uso terapêutico , Adulto , Doenças do Ânus , Povo Asiático , Estudos de Coortes , Doença de Crohn/mortalidade , Procedimentos Cirúrgicos do Sistema Digestório , Feminino , Previsões , Humanos , Masculino , Estudos Multicêntricos como Assunto , Análise de Regressão , Estudos Retrospectivos , Risco , Fumar/efeitos adversos , Taxa de Sobrevida , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
2.
Scand J Infect Dis ; 46(1): 46-51, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24106984

RESUMO

Advancing age is a well-known risk factor for Clostridium difficile infection (CDI). However, age-specific clinical differences in CDI are uncertain. A retrospective comparative analysis was performed based on age in 1367 patients with CDI in Korea. Most clinical features were similar in the two age groups studied, however malignancy was more common in the older group (age ≥ 65 y) (p < 0.001), while chemotherapy and transplantation were more common in the younger group (age < 65 y) (p < 0.001). Endoscopic examinations were more commonly performed in the older group (p = 0.010), which had a high positive predictive value (88.3%). More patients recovered from CDI without specific antibiotic treatment in the younger group than in the older group (p < 0.001). Although advancing age is an important risk factor for CDI, the clinical features of younger patients are similar to those of the older patient population.


Assuntos
Antibacterianos/efeitos adversos , Clostridioides difficile/isolamento & purificação , Infecções por Clostridium/epidemiologia , Infecções por Clostridium/patologia , Diarreia/epidemiologia , Diarreia/patologia , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/uso terapêutico , Criança , Pré-Escolar , Infecções por Clostridium/microbiologia , Diarreia/microbiologia , Feminino , Humanos , Lactente , Coreia (Geográfico) , Masculino , Pessoa de Meia-Idade , Adulto Jovem
3.
Dig Dis Sci ; 57(1): 142-7, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21811829

RESUMO

BACKGROUND AND STUDY AIMS: There is general consensus that water instillation helps insert a colonoscope. However, the most effective method for water instillation has not yet been established, especially for endoscopists-in-training. The aim of this study was to determine volume and temperature for effective water instillation colonoscopy. PATIENTS AND METHODS: This is a prospective, randomized, controlled trial that was carried out at a single center, and a total of 207 consecutive subjects who underwent colonoscopic examination for health checkup were included in the study. Water instillation of supplied water was conducted under four different conditions: 100 and 300 ml at room temperature, 300 ml at 30 °C and no use of water instillation. The following parameters were recorded and analyzed: intubation success rate, independent predictors of successful intubation and intubation time to reach the cecum. RESULTS: The intubation success rate was not significantly different between individual groups. Independent predictors of successful intubation were younger age (P = 0.004) and later examined subjects (P = 0.016). The 300-ml warm water instillation during colonoscopy significantly reduced intubation time over the conventional method without water instillation (P = 0.034). CONCLUSIONS: Instillation of 300-ml warm (30 °C) water during colonoscopy can reduce cecal intubation time for in-training endoscopists without improving the intubation success rate.


Assuntos
Colonoscopia/educação , Colonoscopia/métodos , Educação/métodos , Intubação/métodos , Temperatura , Água , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Dor/prevenção & controle , Valor Preditivo dos Testes , Estudos Prospectivos , Fatores de Tempo , Resultado do Tratamento
4.
Korean J Intern Med ; 32(1): 69-78, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27338135

RESUMO

BACKGROUND/AIMS: The aim of this study was to compare the clinical features and outcomes of ulcerative colitis (UC) according to the age of onset in Korea. METHODS: A total of 1,141 patients who were diagnosed with UC between July 1987 and November 2013 at 11 tertiary hospitals were enrolled. The baseline disease characteristic and disease state at onset, treatment during the disease course were retrospectively reviewed among patients with young-onset (YO, < 20 years) and adult-onset (AO, ≥ 20 years). Severe outcome was defined as use of intravenous (IV) steroids, infliximab, immunosuppressant, or UC-related operation. RESULTS: There were 55 YO patients (mean age, 17.8 ± 2.4) and 1,086 AO patients (mean age, 43.0 ± 13.6). High Mayo scores (7.7 ± 3.0 vs. 5.6 ± 2.7, p = 0.000), extensive UC (52.7% vs. 25.8%, p = 0.000) and IV steroid (41.8% vs. 18.0%, p = 0.000), immunosuppressant (47.3% vs. 26.9%, p = 0.002), and infliximab (20.0% vs. 7.2%, p = 0.001) use were more frequent in the YO than in the AO group. According to multivariate analysis, severe outcomes were related to YO disease (hazard ratio [HR], 2.18; 95% confidence interval [CI], 1.27 to 3.71), body mass index < 23 kg/m2 (HR, 1.46; 95% CI, 1.07 to 2.00), severe (HR, 2.29; 95% CI, 1.36 to 3.38), and moderate (HR, 2.48; 95% CI, 1.67 to 3.67) disease, extensive UC (HR, 2.90; 95% CI, 1.79 to 4.69), UC-related admission (HR, 63.89; 95% CI, 20.41 to 200.02), and oral steroid use (HR, 0.51; 95% CI, 0.39 to 0.67). CONCLUSIONS: UC with YO presented with more advanced clinical features at onset and more severe outcomes than the AO. YO cases require careful management and intense treatment strategies.


Assuntos
Colite Ulcerativa/diagnóstico , Colite Ulcerativa/terapia , Procedimentos Cirúrgicos do Sistema Digestório , Imunossupressores/administração & dosagem , Administração Intravenosa , Administração Oral , Adolescente , Adulto , Idade de Início , Distribuição de Qui-Quadrado , Colite Ulcerativa/epidemiologia , Procedimentos Cirúrgicos do Sistema Digestório/efeitos adversos , Feminino , Humanos , Imunossupressores/efeitos adversos , Infliximab/administração & dosagem , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Modelos de Riscos Proporcionais , República da Coreia/epidemiologia , Estudos Retrospectivos , Índice de Gravidade de Doença , Esteroides/administração & dosagem , Centros de Atenção Terciária , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
5.
Korean J Intern Med ; 29(3): 370-4, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24851072

RESUMO

Various adverse events have been reported during combination therapy with pegylated (PEG)-interferon-α and ribavirin, although opportunistic infections, especially cryptococcal meningitis, are very rare. A 61-year-old woman complained of headaches and a fever during treatment of a chronic hepatitis C virus (HCV) infection. She had been treated for 7 months. Her headaches were refractory to analgesics, and she developed subtle nuchal rigidity. The cerebral spinal fluid (CSF) revealed a white blood cell count of 205/mm(3), 51 mg/dL protein, 35 mg/dL glucose, and negative Cryptococcus antigen. The CSF culture resulted in no growth. Five days later, the CSF was positive for Cryptococcus antigen. We administered amphotericin B and flucytosine, followed by fluconazole. Approximately 2 months later, she was discharged. For the first time, we report a case of cryptococcal meningitis during the treatment of chronic HCV with PEG-interferon-α and ribavirin.


Assuntos
Antivirais/efeitos adversos , Cryptococcus neoformans/patogenicidade , Hepatite C Crônica/tratamento farmacológico , Interferon-alfa/efeitos adversos , Meningite Criptocócica/microbiologia , Infecções Oportunistas/microbiologia , Polietilenoglicóis/efeitos adversos , Ribavirina/efeitos adversos , Antifúngicos/uso terapêutico , Cryptococcus neoformans/imunologia , Quimioterapia Combinada , Feminino , Hepatite C Crônica/diagnóstico , Hepatite C Crônica/imunologia , Humanos , Hospedeiro Imunocomprometido , Interferon alfa-2 , Meningite Criptocócica/tratamento farmacológico , Meningite Criptocócica/imunologia , Pessoa de Meia-Idade , Infecções Oportunistas/diagnóstico , Infecções Oportunistas/tratamento farmacológico , Infecções Oportunistas/imunologia , Proteínas Recombinantes/efeitos adversos , Fatores de Tempo , Resultado do Tratamento
6.
World J Gastroenterol ; 15(12): 1487-92, 2009 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-19322923

RESUMO

AIM: To determine the frequency and characteristics of extracolonic lesions detected using computed tomographic (CT) colonography. METHODS: The significance of extracolonic lesions was classified as high, intermediate, or low. Medical records were reviewed to establish whether further investigations were carried out pertaining to the extracolonic lesions that were detected by CT colonography. RESULTS: A total of 920 cases from 7 university hospitals were included, and 692 extracolonic findings were found in 532 (57.8%) patients. Of 692 extracolonic findings, 60 lesions (8.7%) were highly significant, 250 (36.1%) were of intermediate significance, and 382 (55.2%) were of low significance. CT colonography revealed fewer extracolonic findings in subjects who were without symptoms (P < 0.001), younger (P < 0.001), or who underwent CT colonography with no contrast enhancement (P = 0.005). CT colonography with contrast enhancement showed higher cost-effectiveness in detecting highly significant extracolonic lesions in older subjects and in subjects with symptoms. CONCLUSION: Most of the extracolonic findings detected using CT colonography were of less significant lesions. The role of CT colonography would be optimized if this procedure was performed with contrast enhancement in symptomatic older subjects.


Assuntos
Colo/diagnóstico por imagem , Colo/patologia , Colonografia Tomográfica Computadorizada/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças Ósseas/diagnóstico por imagem , Doenças Ósseas/patologia , Calcinose/diagnóstico por imagem , Meios de Contraste , Fígado Gorduroso/diagnóstico por imagem , Fígado Gorduroso/patologia , Feminino , Hospitais Universitários , Humanos , Aumento da Imagem , Infarto/diagnóstico por imagem , Infarto/patologia , Nefropatias/diagnóstico por imagem , Nefropatias/patologia , Coreia (Geográfico) , Masculino , Pessoa de Meia-Idade , Pleura/diagnóstico por imagem , Pleura/patologia , Hiperplasia Prostática/diagnóstico por imagem , Hiperplasia Prostática/patologia , Sensibilidade e Especificidade
7.
Gastrointest Endosc ; 66(3 Suppl): S22-5, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17709024

RESUMO

BACKGROUND: Double balloon endoscopy (DBE) is a new diagnostic and therapeutic tool for the management of patients with small-bowel disease. OBJECTIVE: To evaluate the feasibility, clinical usefulness, and safety of DBE in Korean patients with suspected or known small-bowel disease. DESIGN: Retrospective, multicenter study from April 2004 to March 2006. SETTING: University hospitals. PATIENTS: Two hundred twenty-five consecutive patients. INTERVENTIONS: Subjects underwent 311 procedures with DBE via the oral and/or anal routes. MAIN OUTCOME MEASUREMENTS: The indications, diagnostic yield, therapeutic use, and complications. RESULTS: Overall diagnostic yield was 75% (169/225). Diagnostic yields for obscure GI bleeding (OGIB) (n = 137), chronic abdominal pain (n = 32), radiologic/capule endoscopic abnormality (n = 25), polyposis (n = 9), and chronic diarrhea (n = 9) were 73.7% (101/137), 75.0% (24/32), 64% (16/25), 100% (9/9), and 0% (0/9), respectively. In patients with OGIB, ulcerating lesions (n = 54) were more common than vascular lesions (n = 20) or tumors (n = 27). Some lesions detected in DBE were treated effectively with electrocoagulation or argon plasma coagulation, polypectomy, and dilation. Entrapped capsules were removed easily with polypectomy snare in 3 patients with small-bowel stricture. Some patients with strictures had transient abdominal discomfort during and/or after the procedure. With the exception of 1 mucosal tear, there were no technical problems or serious complications. LIMITATIONS: Descriptive, retrospective study. CONCLUSIONS: DBE is safe and useful for diagnosis and treatment of a variety of small-bowel diseases. The most common indication of DBE was OGIB. Ulcerating small-bowel lesions are more common than vascular lesions in Korea.


Assuntos
Dor Abdominal/etiologia , Diarreia/etiologia , Endoscópios Gastrointestinais , Hemorragia Gastrointestinal/etiologia , Enteropatias/diagnóstico , Intestino Delgado , Endoscopia por Cápsula , Doença Crônica , Diagnóstico Diferencial , Desenho de Equipamento , Estudos de Viabilidade , Hemorragia Gastrointestinal/terapia , Humanos , Enteropatias/terapia , Neoplasias Intestinais/diagnóstico , Pólipos Intestinais/diagnóstico , Coreia (Geográfico) , Estudos Retrospectivos , Sensibilidade e Especificidade , Resultado do Tratamento , Úlcera/diagnóstico , Úlcera/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA